Keyphrases
Insulin-like
41%
Growth Factors
41%
Growth Hormone
40%
Neuroendocrine Neoplasms
38%
Systematic Meta-analysis
30%
Neuroendocrine Tumor
27%
After Surgery
27%
Insulin-like Growth factor-1
27%
Copenhagen
25%
Pancreatic Neuroendocrine Tumors (pNETs)
23%
Semen Quality
22%
Meta-analysis
22%
Hormone Levels
21%
Tumor
19%
Ki-67 Index
18%
Transsphenoidal Surgery
18%
Peptide Receptor Radionuclide Therapy
17%
Growth Hormone Deficiency
16%
All-cause Mortality
16%
B-type Natriuretic Peptide
16%
Lymph Node Metastasis
16%
Center of Excellence
16%
Positron Emission Tomography-computed Tomography (PET-CT)
15%
Small Intestinal Neuroendocrine Tumors
15%
Disease-specific Survival
15%
Contralateral Suppression
15%
Non-functioning pituitary Adenoma
15%
Insulinoma
15%
Interleukin-6
15%
YKL-40
15%
Dopamine Agonist
15%
Primary Aldosteronism
15%
Prognostic Value
15%
Inflammation Markers
15%
Ki-67
14%
Circulating Levels
14%
Inflammatory Process
13%
Tumor Size
13%
Cardiac Function
13%
Pituitary Function
13%
Pituitary
12%
Chronic Heart Failure
12%
Medical Treatment
12%
Chromogranin A
11%
Metastasis
11%
Left Ventricular Mass
11%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
11%
Cardiac Magnetic Resonance Imaging (cMRI)
11%
Appendiceal Neuroendocrine Neoplasms
11%
Median Progression-free Survival
11%
Medicine and Dentistry
Neuroendocrine Tumor
100%
Neoplasm
59%
Somatomedin C
29%
Growth Hormone
27%
Meta-Analysis
22%
Systematic Review
22%
Primary Hyperaldosteronism
22%
Acromegaly
20%
Disease
20%
Diagnosis
19%
Magnetic Resonance Imaging
19%
Metastatic Carcinoma
18%
Cohort Analysis
18%
Peptide Receptor
17%
Transsphenoidal Surgery
17%
Surgery
17%
Radionuclide Therapy
16%
Retrospective Study
16%
Lymph Node Metastasis
16%
Recurrence Risk
16%
Brain Natriuretic Peptide
15%
Adrenalectomy
15%
Insulin-Like Growth Factor 1
15%
Vermiform Appendix
15%
Nonfunctioning Pituitary Adenoma
15%
Nesidioblastosis
15%
Disease Specific Survival
15%
Positron Emission Tomography-Computed Tomography
15%
Volunteer
15%
Contralateral
15%
Multiple Endocrine Neoplasia Type I
15%
Combination Therapy
13%
All Cause Mortality
13%
Hypophysis Function
13%
Primary Tumor
12%
Amino Terminal Sequence
12%
Progression Free Survival
12%
Reproductive Hormone
11%
Serositis
11%
Hormone Determination
11%
Hormone Action
11%
Chromogranin A
11%
Recurrence Free Survival
10%
Neuroendocrine Carcinoma
9%
Heart Function
9%
Somatostatin Receptor
9%
Hydrocortisone
9%
Pancreas Islet Cell Tumor
9%
Gallium 68
9%
Adjuvant Therapy
9%
